Federal Contracting

Gilead Fraud Case Too Burdensome, Justice Department Says

March 29, 2019, 2:33 PM

The Justice Department moved to dismiss Jeffrey and Sherilyn Campie’s false claims case against drugmaker Gilead Sciences Inc. as it told the Supreme Court it would in November.

The DOJ is entitled to prosecutorial discretion under the False Claims Act when it decides to end a whistleblower’s case, it told the U.S. District Court for the Northern District of California.

The move to terminate claims accusing Gilead providing defective HIV drugs would save “scarce” government resources on a case the Justice Department investigated and decided not to pursue.

The False Claims Act provides that DOJ may seek dismissal if a...

To read the full article log in. To learn more about a subscription click here.